Pakistan Healthcare and Pharmaceutical Market Report 2019 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Healthcare
and Pharmaceutical Market in Pakistan” report has been added to ResearchAndMarkets.com’s
offering.

This report on the Healthcare and Pharmaceutical Market in Pakistan
provides comprehensive coverage of the entire sector from 2012 till 2022.

The pharmaceutical industry in Pakistan is growing at a rapid pace,
contributing significantly to the national economy. In the last couple
of years, the Pakistani economy has been suffering due to bad economic
conditions and also been under strain due to the war against terrorism.
The economy is also facing the problem of domestic inflation, slow
economic growth, as well as the devaluation of the Pakistani rupee
against other major currencies.

Pakistani pharmaceutical and healthcare industries are very competitive
and challenging. There are nearly 600 pharmaceutical companies operating
in Pakistan, with major global leaders having a presence in the country.
The industry presents a lot of growth opportunities for drug makers,
with the opportunities being driven by the rising burden of chronic
disease and launch of the Pakistani national health insurance program.

However, there are many challenges that the industry faces, with
regulatory and pricing challenges being at the top of the list. With the
government’s focus on boosting the pharmaceutical and healthcare market,
the industry is poised for good growth, with many opportunities present
for drawing in foreign investment.

In this industry scenario, the author presents an analysis of the
Healthcare and Pharmaceutical Market in Pakistan.

The report analyzes the following points:

• Analysis of the healthcare and pharmaceutical market through an
  industry overview, overview of the healthcare segment, an overview of
  the pharmaceutical sector, the prevalence of diseases in Pakistan,
  industry drivers, investment, market distribution, healthcare
  expenditure, etc.
• Competition in the industry and generic players in Pakistan
• Major market activity by the leading drug makers
• Global trends and how the Pakistani industry compares
• SWOT analysis of the Pakistani healthcare and pharmaceutical market
• Regulatory landscape governing the industry in Pakistan
• A look at the industry research and development
• Industry challenges
• Forecast of the industry including a separate forecast for healthcare
  and pharmaceutical sector forecast
• Analysis of the major industry players with a company profile,
  presence in Pakistan, and a SWOT analysis

Key Topics Covered:

1. Executive Summary

2. Healthcare and Pharmaceutical Market in Pakistan

2.1 Industry Overview

2.2 Healthcare Segment

2.3 Pharmaceutical Sector

2.4 Prevalence of Diseases in Pakistan

2.5 Industry Drivers

2.6 Industry Investment

2.7 Market Distribution

2.8 Healthcare Expenditure

2.9 Competition in the Industry

2.10 Generic Players in Pakistan

2.11 Market Activity by Major Drug Makers

2.12 Global Trends and how the Pakistani Industry Measures

3. Healthcare and Pharmaceutical Market in Pakistan: SWOT
Analysis

3.1 Overview

3.2 Strengths

3.3 Weaknesses

3.4 Opportunities

3.5 Threats

4. Regulatory Landscape

4.1 Overview

4.2 Drug Pricing

4.3 Issue over Intellectual Property Rights

4.4 Reimbursement Policy

5. Industry Research and Development

5.1 Overview

5.2 Technology Adaptation in the Industry

5.3 Clinical Trials

5.4 Pharmaceutical R&D

6. Industry Challenges

6.1 No Health System Governance

6.2 No Health Equity in Pakistan

6.3 Lack of Resources and Poor Infrastructure

6.4 Other Challenges

7. Healthcare and Pharmaceutical Market in Pakistan: Forecast

7.1 Healthcare Forecast

7.2 Pharmaceutical Forecast

7.3 Future Trends

7.3.1 Healthcare Trends

7.3.2 Pharmaceutical Trends

8. Industry Players

• Abbott Laboratories (Pakistan)
• Efroze Chemical Industries
• Ferozsons Laboratories
• Getz Pharma
• GlaxoSmithKline Pakistan
• Hilton Pharma
• Novartis Pakistan
• Pfizer Pakistan Limited
• Sanofi-Aventis
• SEARLE Company Limited

For more information about this report visit https://www.researchandmarkets.com/r/j1fw6f

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Healthcare
Services, Pharmaceuticals